Items tagged with Access

India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline (post with simple image)

Médecins Sans Frontières urges the Indian Patent Office to reject the secondary patent application filed by Johnson & Johnson to prevent the company from extending its monopoly on bedaquiline beyond the primary patent’s expiry in July 2023.

Updates from the 1/4/6x24 Campaign (post with simple image)

A few recent Campaign updates from Treatment Action Group and allies.
Contact for more information on how to be part of the 1/4/6x24 Campaign.

Urgent action necessary to improve equitable access to GeneXpert TB diagnostics and achieve 1/4/6x24 (post with simple image)

Advocates urge Cepheid to take immediate action necessary to bring about affordable, equitable, and expanded access to GeneXpert TB testing.

Action needed to scale up access to shorter, safer TB prevention and treatment regimens (post with simple image)

A push to include the latest WHO-recommended TB regimens in the current round of funding requests to the Global Fund.

1/4/6x24 Campaign videos & World TB Day Toolkit (post with simple image)

Treatment Action Group and the 1/4/6x24 Campaign Coalition launch the 1/4/6x24 World TB Day Toolkit to support advocacy the week of World TB Day for access to shorter, safer regimens for TB prevention and treatment.

TAG applauds price reduction of Molbio’s Truenat diagnostics for TB (post with simple image)

TAG applauds Molbio’s agreement with the Stop TB Partnership, USAID, and the Global Fund to reduce the price of Truenat diagnostics for TB from US$9 per test to $7.90 per test and to provide quality service and maintenance of Truenat testing instruments globally.

The 1/4/6×24 Campaign Coalition welcomes India’s rejection of Johnson & Johnson’s patent evergreening tactic (post with simple image)

The Indian Patent Office has taken a laudable step that will pave the way for generic manufacturing of a key TB drug.

Page 75 of 75 · Total posts: 0

←First 74 75